New eye drops aim to tackle blinding disease – first safety check in humans
NCT ID NCT06969001
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 21 times
Summary
This early-stage study tested whether SCAI-005 eye drops are safe and how they move through the body in 48 healthy Korean adults. The goal is to develop a convenient eye drop treatment for wet age-related macular degeneration, a leading cause of vision loss. No results are available yet, as this trial focused only on safety and dosing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WET AGE RELATED MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Catholic University, Seoul ST. Mary's Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.